Publication | Closed Access

Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial

Breast OncologyMedicinePharmacologyGynecologyAdjuvant TamoxifenBreast CancerMenopausePharmacotherapyAbcsg Trial 8Menopause Hormone TherapyOncologyEndocrine-related CancerArno 95